alopecia
Information
- Disease name
- alopecia
- Disease ID
- DOID:987
- Description
- "A hypotrichosis that is characterized by a loss of hair from the head or body." [url:http\://en.wikipedia.org/wiki/Alopecia, url:http\://www.omim.org/entry/109200?search=109200&highlight=109200]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04721548 | Active, not recruiting | Phase 3 | Treatment of Androgenetic Alopecia in Men for 24 Weeks | March 2, 2023 | September 30, 2024 |
NCT04459650 | Active, not recruiting | Early Phase 1 | A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer | June 23, 2020 | June 2024 |
NCT03382184 | Active, not recruiting | Early Phase 1 | Fractional Photothermolysis for Hair Follicle Induction | October 20, 2017 | December 2026 |
NCT00441116 | Completed | Phase 3 | A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia | December 15, 2006 | January 21, 2008 |
NCT00515762 | Completed | Phase 2 | Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling | May 2007 | June 2010 |
NCT01590238 | Completed | Phase 3 | Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM) | May 2012 | November 2013 |
NCT00177099 | Completed | Phase 1 | Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice | July 2003 | September 2004 |
NCT00179348 | Completed | N/A | Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer | February 8, 2001 | July 20, 2016 |
NCT01004809 | Completed | AVODART® Alopecia Post-marketing Surveillance (PMS) | April 29, 2010 | December 21, 2012 | |
NCT01008774 | Completed | N/A | START: Swiss Taxotere Alopecia Prevention Trial | July 2009 | October 2011 |
NCT01145625 | Completed | Phase 3 | Clinical Trial in Females With Female Pattern Hair Loss | June 2010 | February 2012 |
NCT01189279 | Completed | Phase 1 | Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia | October 2010 | February 2011 |
NCT01325337 | Completed | Phase 2 | Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia | June 2011 | September 2012 |
NCT01325350 | Completed | Phase 2 | Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss | June 2011 | September 2012 |
NCT01831791 | Completed | Phase 3 | A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia | April 14, 2013 | July 19, 2014 |
NCT01904721 | Completed | Phase 2 | A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) | August 2013 | January 2015 |
NCT01929330 | Completed | Phase 1 | Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers | September 23, 2013 | January 9, 2014 |
NCT02014584 | Completed | Phase 3 | Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia | July 2, 2014 | March 19, 2016 |
NCT02206802 | Completed | Minoxidil Response Testing in Females With Female Pattern Hair Loss | July 2014 | October 2018 | |
NCT02605629 | Completed | N/A | EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors | July 13, 2016 | June 9, 2017 |
NCT02781311 | Completed | Phase 2 | A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males | July 14, 2016 | May 22, 2018 |
NCT02793557 | Completed | Phase 1/Phase 2 | Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth | January 2016 | March 2017 |
NCT02919735 | Completed | Phase 2 | Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN) | October 2016 | March 1, 2019 |
NCT02986412 | Completed | N/A | A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2) | January 15, 2016 | December 15, 2017 |
NCT03331003 | Completed | N/A | "iRestore" Light Therapy Apparatus | March 30, 2015 | December 15, 2016 |
NCT03351322 | Completed | Phase 2 | ENERGI-F701 for Female Hair Loss Treatment | May 23, 2018 | December 26, 2019 |
NCT03488108 | Completed | Phase 1/Phase 2 | Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women | January 23, 2017 | June 17, 2019 |
NCT03594227 | Completed | Phase 2 | ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis | June 11, 2018 | June 18, 2019 |
NCT03689452 | Completed | N/A | The Effect of Platelet Rich Plasma on Non-scarring Alopecia | October 1, 2018 | June 3, 2019 |
NCT04117815 | Completed | Hair-Safe Study: Scalp Cooling for Hair Saving in Women Undergoing Chemotherapy | May 18, 2018 | February 28, 2021 | |
NCT04205214 | Completed | N/A | A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia | December 1, 2018 | February 13, 2020 |
NCT04246957 | Completed | Quality of Life Comparison in Patients With Different Types of Alopecia | March 4, 2019 | November 16, 2020 | |
NCT04492800 | Completed | N/A | Hair Loss Prevention Study for Pancreatic Cancer | December 13, 2019 | December 31, 2021 |
NCT04554732 | Completed | Early Phase 1 | Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia | April 27, 2020 | June 24, 2022 |
NCT04805606 | Completed | Phase 1 | A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 | April 30, 2021 | December 24, 2021 |
NCT04897555 | Completed | N/A | LLLT for Alopecia of the Eyebrow in Women | May 1, 2019 | October 1, 2019 |
NCT05218642 | Completed | Phase 2 | To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia | January 31, 2022 | February 13, 2023 |
NCT05587699 | Completed | Phase 1 | The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A | November 15, 2022 | October 17, 2023 |
NCT05589610 | Completed | Phase 2 | Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata | December 19, 2022 | April 30, 2024 |
NCT05630027 | Completed | A Scalp Lotion Toimprove Sensitive Scalp Syndrome | January 2, 2019 | June 30, 2020 | |
NCT06095739 | Completed | N/A | Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002 | November 18, 2022 | January 2, 2023 |
NCT06409650 | Completed | Phase 2 | To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia | November 9, 2021 | December 7, 2023 |
NCT05484973 | Not yet recruiting | N/A | Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss | March 31, 2024 | September 30, 2025 |
NCT05544448 | Not yet recruiting | N/A | In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases | October 15, 2022 | April 15, 2023 |
NCT06355856 | Not yet recruiting | Phase 4 | Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss | April 2024 | May 2025 |
NCT06292533 | Not yet recruiting | N/A | Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study | June 2024 | October 2024 |
NCT06283316 | Recruiting | Systemic Treatments for Alopecia Areata Registry | January 17, 2024 | December 31, 2099 | |
NCT06215469 | Recruiting | N/A | Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) | May 16, 2024 | August 31, 2025 |
NCT03840928 | Recruiting | PatientSpot Formerly Known as ArthritisPower | April 1, 2015 | March 1, 2025 | |
NCT04014413 | Recruiting | N/A | Safety and Efficacy of Fecal Microbiota Transplantation | July 15, 2019 | October 31, 2030 |
NCT05658094 | Recruiting | N/A | Exosome Effect on Prevention of Hairloss | August 1, 2022 | October 29, 2023 |
NCT05723198 | Recruiting | Phase 3 | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata | February 27, 2023 | August 2029 |
NCT04764357 | Recruiting | N/A | Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors | June 4, 2021 | December 2025 |
NCT05778825 | Recruiting | Phase 2 | A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors | March 10, 2023 | March 2026 |
NCT05779527 | Recruiting | N/A | Mindful Parenting - A Single Case Experimental Design Study | January 3, 2023 | April 14, 2023 |
NCT05213936 | Recruiting | N/A | Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color | October 24, 2022 | January 2025 |
NCT02935569 | Terminated | N/A | Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy | May 2012 | August 2014 |
NCT00713154 | Terminated | Phase 2 | Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy | April 2007 | September 2008 |
NCT00129415 | Terminated | Phase 1/Phase 2 | Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions | August 2000 | January 2011 |
NCT01367990 | Terminated | Phase 1 | Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy | July 2011 | April 2012 |
NCT05761158 | Terminated | Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris | March 14, 2023 | May 25, 2023 | |
NCT01385839 | Terminated | N/A | Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata | October 2009 | May 2012 |
NCT02676310 | Terminated | Phase 1 | Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) | March 2016 | March 2017 |
NCT00418249 | Unknown status | Phase 2 | Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women | ||
NCT02591823 | Unknown status | Hair Fall in Patients on Low Dose Methotrexate | October 2015 | May 2016 | |
NCT02393040 | Unknown status | N/A | Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia | January 2014 | November 2015 |
NCT01557491 | Unknown status | N/A | Hair Regrowth After Bicoronal Incision | May 2012 | |
NCT01651689 | Unknown status | Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia | October 2010 | May 2013 | |
NCT00197379 | Unknown status | N/A | The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia | May 2005 | January 2007 |
NCT01986140 | Unknown status | N/A | Scalp Cooling to Prevent Chemo-induced Hair Loss | May 15, 2014 | December 2022 |
NCT03662854 | Unknown status | Phase 1 | Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss | July 2, 2018 | January 21, 2021 |
NCT04834102 | Unknown status | COVID-19 Induced Telogen Effluvium | January 27, 2021 | April 27, 2021 | |
NCT03427905 | Unknown status | N/A | Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for Alopecia | January 27, 2017 | December 30, 2018 |
NCT01111981 | Unknown status | Phase 4 | Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia | October 2009 | October 2010 |
NCT00801086 | Unknown status | Phase 2 | Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain | November 2008 | June 2010 |
NCT04953416 | Unknown status | N/A | Fractional Non-ablative Laser for the Treatment of Hair Loss | September 8, 2020 | March 2022 |
NCT05129800 | Unknown status | Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study | December 2021 | February 2022 | |
NCT02856308 | Unknown status | N/A | Hairstetics Hair Implant Device Safety and Efficacy | March 2014 | September 2018 |
NCT05210452 | Unknown status | Phase 1/Phase 2 | Treatment of Alopecia Using Follicular Stem Cells | March 1, 2022 | December 31, 2023 |
NCT04036994 | Unknown status | N/A | PBMT for the Management of CIA ( HAIRLASER ) | June 17, 2020 | December 31, 2022 |
NCT05365243 | Withdrawn | N/A | A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads | August 15, 2022 | September 30, 2023 |
NCT00999557 | Withdrawn | N/A | Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants | January 2016 | |
NCT03284021 | Withdrawn | N/A | Fraxel Laser for Alopecia | April 24, 2019 | April 24, 2019 |
- Disase is a (Disease Ontology)
- DOID:4535
- Cross Reference ID (Disease Ontology)
- ICD10CM:L65.9
- Cross Reference ID (Disease Ontology)
- ICD9CM:704.0
- Cross Reference ID (Disease Ontology)
- MESH:D000505
- Cross Reference ID (Disease Ontology)
- MIM:PS203655
- Cross Reference ID (Disease Ontology)
- NCI:C50575
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:270504008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0002170
- HPO alt_id (Human Phenotype Ontology)
- HP:0002238
- HPO alt_id (Human Phenotype Ontology)
- HP:0008068
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001596
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000505